These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31656151)
1. Inhibitors of Cholinesterases in Pharmacology: the Current Trends. Pohanka M Mini Rev Med Chem; 2020; 20(15):1532-1542. PubMed ID: 31656151 [TBL] [Abstract][Full Text] [Related]
2. Cholinesterases, a target of pharmacology and toxicology. Pohanka M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):219-29. PubMed ID: 22286807 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological Influencing of The Cholinergic Anti-inflammatory Pathway in Infectious Diseases and Inflammatory Pathologies. Pohanka M Mini Rev Med Chem; 2021; 21(6):660-669. PubMed ID: 33208075 [TBL] [Abstract][Full Text] [Related]
4. Coumarins as cholinesterase inhibitors: A review. de Souza LG; Rennã MN; Figueroa-Villar JD Chem Biol Interact; 2016 Jul; 254():11-23. PubMed ID: 27174134 [TBL] [Abstract][Full Text] [Related]
5. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713 [TBL] [Abstract][Full Text] [Related]
6. Cholinesterase as a Target for Drug Development in Alzheimer's Disease. Sharma P; Tripathi MK; Shrivastava SK Methods Mol Biol; 2020; 2089():257-286. PubMed ID: 31773661 [TBL] [Abstract][Full Text] [Related]
7. Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies. Darreh-Shori T; Soininen H Curr Alzheimer Res; 2010 Feb; 7(1):67-73. PubMed ID: 20205672 [TBL] [Abstract][Full Text] [Related]
8. Ferulic acid and Alzheimer's disease: promises and pitfalls. Nabavi SF; Devi KP; Malar DS; Sureda A; Daglia M; Nabavi SM Mini Rev Med Chem; 2015; 15(9):776-88. PubMed ID: 26002710 [TBL] [Abstract][Full Text] [Related]
15. An update on the pharmacology of galantamine. Villarroya M; García AG; Marco-Contelles J; López MG Expert Opin Investig Drugs; 2007 Dec; 16(12):1987-98. PubMed ID: 18042006 [TBL] [Abstract][Full Text] [Related]
16. A review on cholinesterase inhibitors for Alzheimer's disease. Anand P; Singh B Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942 [TBL] [Abstract][Full Text] [Related]